Menu Back to 8th-European-Forum-for-Qualified-Person-for-Pharmacovigilance-QPPV-and-Pre-conference-Workshop

Program Committee

  • Peter  De Veene, MD
    Peter De Veene, MD Head Global Drug Safety & QPPV
    Grunenthal GmbH, Germany
  • Margaret Anne Walters
    Margaret Anne Walters Director & Deputy EU Qualified Person for Pharmacovigilance
    Merck, Sharp & Dohme Ltd, United Kingdom
  • Elspeth  McIntosh
    Elspeth McIntosh Director
    Castle Pharmacovigilance Ltd, United Kingdom
  • Doris Irene Stenver, MD, MPA
    Doris Irene Stenver, MD, MPA Chief Medical Officer
    Danish Medicines Agency, Denmark
  • Vicki  Edwards, RPh
    Vicki Edwards, RPh QPPV and Head of Affiliate Vigilance Excellence
    AbbVie Ltd., United Kingdom
  • Michael  Richardson, MD, FFPM
    Michael Richardson, MD, FFPM VP International GPV&E and EU QPPV
    Bristol-Myers Squibb, United Kingdom
  • Brian David Edwards
    Brian David Edwards Principal Consultant, Pharmacovigilance and Drug Safety, Vice-President ACRES
    NDA Regulatory Science Ltd., United Kingdom
  • Natalia  Kocankova, MD, MBA
    Natalia Kocankova, MD, MBA Director PV, EU QPPV
    Xantis Pharma s.r.o., Czech Republic
Load More